Back
Corvus Pharmaceuticals Stock Price Chart
Buy
84
CRVS
Corvus Pharmaceuticals
Last Price:
2.29
Seasonality Move:
3.43%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corvus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.14 | Buy |
| 20-day SMA: | 1.83 | Buy |
| 50-day SMA: | 1.78 | Buy |
| 200-day SMA: | 1.79 | Buy |
| 8-day EMA: | 2.13 | Buy |
| 20-day EMA: | 1.94 | Buy |
| 50-day EMA: | 1.85 | Buy |
| 200-day EMA: | 1.81 | Buy |
Corvus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 69.2 | Buy |
| Chaikin Money Flow: | 139526 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.44 - 2.06) | Buy |
| Bollinger Bands (100): | (1.68 - 2.22) | Buy |
Corvus Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals Stock
Is Corvus Pharmaceuticals Stock a Buy?
- Corvus Pharmaceuticals share price is 2.29 while CRVS 8-day simple moving average is 2.14, which is a Buy signal.
- The stock price of CRVS is 2.29 while Corvus Pharmaceuticals 20-day SMA is 1.83, which makes it a Buy.
- Corvus Pharmaceuticals 50-day simple moving average is 1.78 while CRVS share price is 2.29, making it a Buy technically.
- CRVS stock price is 2.29 and Corvus Pharmaceuticals 200-day simple moving average is 1.79, creating a Buy signal.
CRVS Technical Analysis vs Fundamental Analysis
Buy
84
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy or a Sell?
-
Corvus Pharmaceuticals stock is rated a Buy
The current Corvus Pharmaceuticals [CRVS] share price is $2.29. The Score for CRVS is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
Corvus Pharmaceuticals Stock Info
Market Cap:
143.24M
Price in USD:
2.29
Share Volume:
246.85K
Corvus Pharmaceuticals 52-Week Range
52-Week High:
4.19
52-Week Low:
1.05
Buy
84
Corvus Pharmaceuticals (CRVS)
is a Buy
Corvus Pharmaceuticals Share Price Forecast
-
What is the Corvus Pharmaceuticals stock price today?
The Corvus Pharmaceuticals stock price is 2.29 USD today. -
Will CRVS stock go up or go down?
Corvus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Corvus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals is not overvalued.
Is Corvus Pharmaceuticals Stock a Buy?
- Corvus Pharmaceuticals share price is 2.29 while CRVS 8-day exponential moving average is 2.13, which is a Buy signal.
- The stock price of CRVS is 2.29 while Corvus Pharmaceuticals 20-day EMA is 1.94, which makes it a Buy.
- Corvus Pharmaceuticals 50-day exponential moving average is 1.85 while CRVS share price is 2.29, making it a Buy technically.
- CRVS stock price is 2.29 and Corvus Pharmaceuticals 200-day simple moving average is 1.81, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals
Is Corvus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.07 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Corvus Pharmaceuticals
Should I short Corvus Pharmaceuticals stock?
- CRVS Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting Corvus Pharmaceuticals is a Buy
- Corvus Pharmaceuticals Relative Strength Index (RSI) is 69.2, which suggest Corvus Pharmaceuticals is overbought
- The Bollinger Bands (25) for Corvus Pharmaceuticals is (1.44 - 2.06), which suggest Corvus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Corvus Pharmaceuticals is (1.68 - 2.22), which suggest Corvus Pharmaceuticals is a Buy
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.